Us Financial Advisors, LLC Royalty Pharma PLC Transaction History

Us Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$27.46 - $31.33 $9,611 - $10,965	-350 Reduced 4.29%	7,815 $237,000
Q3 2023 Nov 09, 2023	SELL	$26.26 - $31.38 $270,057 - $322,711	-10,284 Reduced 55.74%	8,165 $221,000
Q2 2023 Aug 09, 2023	SELL	$29.6 - $36.56 $127,280 - $157,208	-4,300 Reduced 18.9%	18,449 $567,000
Q4 2022 Jan 26, 2023	BUY	$39.17 - $44.04 $891,078 - $1 Million	22,749 New	22,749 $0

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Us Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Us Financial Advisors, LLC with notifications on news.